Current Atherosclerosis Reports

, Volume 8, Issue 4, pp 290–297 | Cite as

Symptomatic and asymptomatic carotid stenosis: How, when, and who to treat?

Article

Abstract

Carotid stenosis is an important cause of ischemic stroke. Large randomized trials of endarterectomy have shown that surgery reduces the risk of stroke in patients with recently symptomatic carotid stenosis of 50% or greater, and to a lesser extent in patients with asymptomatic carotid stenosis of 60% or greater. More recent research has gone some way in identifying which patients benefit most and when intervention is most effective. Individual risk modeling has been shown to be useful in selecting patients with the most to gain from endarterectomy for symptomatic stenosis, although timely surgery and optimal medical treatment are of equal importance. Further research is required in order to determine the role of carotid stenting and to identify those individuals with asymptomatic stenosis who have the most to gain from intervention.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Lovett JK, Coull A, Rothwell PM, on behalf of the Oxford Vascular Study: Early risk of recurrent stroke by aetiological subtype: implications for stroke prevention. Neurology 2004, 62:569–574.PubMedGoogle Scholar
  2. 2.
    Fairhead JF, Mehta Z, Rothwell PM: Population-based study of delays in carotid imaging and surgery and the risk of recurrent stroke. Neurology 2005, 65:371–375.PubMedCrossRefGoogle Scholar
  3. 3.
    Engelter S, Lyrer P: Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy. Cochrane Database Syst Rev 2003(3):CD001458.Google Scholar
  4. 4.
    International Stroke Trial Collaborative Group: The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both or neither among 19435 patients with acute ischaemic stroke. Lancet 1997, 349:1569–1581.CrossRefGoogle Scholar
  5. 5.
    CAST (Chinese Acute Stroke Trial) Collaborative Group: CAST: randomized placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 1997, 349:1641–1649.CrossRefGoogle Scholar
  6. 6.
    Diener HC, Bogousslavsky J, Brass LM, et al.; on behalf of the MATCH investigators: Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): randomized double-blind, placebo-controlled trial. Lancet 2004, 364:331–337.PubMedCrossRefGoogle Scholar
  7. 7.
    Markus HS, Droste DW, Kaps M, et al.: Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005, 111:2233–2240PubMedCrossRefGoogle Scholar
  8. 8.
    Kennedy J, Eliasziw M, Hill MD, Buchan AM: The Fast Assessment of Stroke and Transient Ischemic Attack to prevent Early Recurrence (FASTER) Trial. Semin Cerebrovasc Dis Stroke 2003, 3:25–30CrossRefGoogle Scholar
  9. 9.
    Rothwell PM, Buchan A, Johnston SC: Recent advances in the management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 2006, 5:323–331.PubMedCrossRefGoogle Scholar
  10. 10.
    Leonardi-Bee J, Bath PM, Bousser MG, et al.; Dipyridamole in Stroke Collaboration (DISC): Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. Stroke 2005, 36:162–168PubMedCrossRefGoogle Scholar
  11. 11.
    Chimowitz MI, Lynn MJ, Howlett-Smith H, et al.; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005, 352:1305–1316PubMedCrossRefGoogle Scholar
  12. 12.
    Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk patients: a randomized placebo-controlled trial. Lancet 2002, 360:722.Google Scholar
  13. 13.
    Heart Protection Study Collaborative Group: Effects of cholesterol lowering with Simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high risk conditions. Lancet 2004, 363:757–767.CrossRefGoogle Scholar
  14. 14.
    Waters DD, Schwartz GG, Olsson AG, et al.; for the MIRACL Study Investigators: Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction. A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation 2002, 106:1690–1695.PubMedCrossRefGoogle Scholar
  15. 15.
    Amarenco P, Bogousslavsky J, Callahan AS, et al.; SPARCL Investigators: Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc Dis 2003, 16:389–395.PubMedCrossRefGoogle Scholar
  16. 16.
    Van der Grond J, Balm R, Kappelle J, et al.: Cerebral metabolism of patients with stenosis or occlusion of the internal carotid artery. Stroke 1995, 26:822–828.PubMedGoogle Scholar
  17. 17.
    Rothwell PM, Howard SC, Spence D: Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 2003, 34:2583–2590.PubMedCrossRefGoogle Scholar
  18. 18.
    Rothwell PM, Eliasziw M, Gutnikov SA, et al.: Analysis of pooled data from the randomized controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003, 361:107–116.PubMedCrossRefGoogle Scholar
  19. 19.
    North American Symptomatic Carotid Endarterectomy Trial Collaborators: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998, 339:1415–1425.CrossRefGoogle Scholar
  20. 20.
    European Carotid Surgery Trialists Collaborative Group: Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998, 351:1379–1387.CrossRefGoogle Scholar
  21. 21.
    Rothwell PM, Gutnikov SA, Warlow CP, for the ECST: Re-analysis of the final results of the European Carotid Surgery Trial. Stroke 2003, 34:514–523.PubMedCrossRefGoogle Scholar
  22. 22.
    Ascher E, Markevich N, Hingorani A, Kallakuri S: Pseudo-occlusions of the internal carotid artery: A rationale for treatment on the basis of a modified duplex scan protocol. J Vasc Surg 2002, 35:340–350.PubMedCrossRefGoogle Scholar
  23. 23.
    Rothwell PM, Eliasziw M, Gutnikov SA, et al.; Carotid Endarterectomy Trialists Collaboration: Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004, 363:915–924.PubMedCrossRefGoogle Scholar
  24. 24.
    Bond R, Rerkasem K, Cuffe R, Rothwell PM: A systematic review of the associations between age and sex and the operative risks of carotid endarterectomy. Cerebrovasc Dis 2005, 20:69–77.PubMedCrossRefGoogle Scholar
  25. 25.
    Johnston SC, Gress DR, Browner WS, Sidney S: Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000, 284:2901–2906.PubMedCrossRefGoogle Scholar
  26. 26.
    Rothwell PM, Giles MF, Flossmann E, et al.: A simple score (ABCD) to identify individuals at high early risk of stroke after a transient ischaemic attack. Lancet 2005, 366:29–36.PubMedCrossRefGoogle Scholar
  27. 27.
    Hill MD, Yiannakoulias N, Jeerakathil T, et al.: The high risk of stroke immediately after transient ischemic attack. A population-based study. Neurology 2004, 62:2015–2020.PubMedGoogle Scholar
  28. 28.
    Rothwell PM, Gibson R, Warlow CP: The interrelation between plaque surface morphology, degree of stenosis and the risk of ischaemic stroke in patients with symptomatic carotid stenosis. Stroke 2000, 31:615–621.PubMedGoogle Scholar
  29. 29.
    Rothwell PM, Gutnikov SA, Eliasziw M, et al.: Sex difference in effect of time from symptoms to surgery on benefit from endarterectomy for transient ischaemic attack and non-disabling stroke. Stroke 2004, 35:2855–2861.PubMedCrossRefGoogle Scholar
  30. 30.
    Bond R, Rerkasem K, Rothwell PM: A systematic review of the risks of carotid endarterectomy in relation to the clinical indication and the timing of surgery. Stroke 2003, 34:2290–2301.PubMedCrossRefGoogle Scholar
  31. 31.
    Fairhead JF, Rothwell PM: The need for urgency in identification and treatment of symptomatic carotid stenosis is already established. Cerebrovasc Dis 2005, 19:355–358.PubMedCrossRefGoogle Scholar
  32. 32.
    Rantner B, Pavelka M, Posch L, et al.: Carotid endarterectomy after ischemic stroke — is there a justification for delayed surgery? Eur J Vasc Endovasc Surg 2005, 30:36–40.PubMedCrossRefGoogle Scholar
  33. 33.
    Rothwell PM: Can overall results of clinical trials be applied to all patients? Lancet 1995, 345:1616–1619.PubMedCrossRefGoogle Scholar
  34. 34.
    Rothwell PM, Warlow CP, on behalf of the ECST Collaborators: Prediction of benefit from carotid endarterectomy in individual patients: A risk-modelling study. Lancet 1999, 353:2105–2110.PubMedCrossRefGoogle Scholar
  35. 35.
    Rothwell PM, Mehta Z, Howard SC, et al.: From subgroups to individuals: general principles and the example of carotid endartectomy. Lancet 2005, 365:256–265.PubMedGoogle Scholar
  36. 36.
    Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995, 273:1421–1428.CrossRefGoogle Scholar
  37. 37.
    Chambers BR, Donnan GA: Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev 2005, (4):CD001923.Google Scholar
  38. 38.
    Tu JV, Hannan EL, Anderson GM, et al.: The fall and rise of carotid endarterectomy in the United States and Canada. N Engl J Med 1998, 339:1441–1447.PubMedCrossRefGoogle Scholar
  39. 39.
    Pell JP, Slack R, Dennis M, Welch G: Improvements in carotid endarterectomy in Scotland: results of a national prospective survey. Scott Med J 2004, 49:53–56.PubMedGoogle Scholar
  40. 40.
    Moore WS, Young B, Baker WH, et al.: Surgical results: a justification of the surgeon selection process for the ACAS trial. J Vasc Surg 1996, 23:323–338.PubMedCrossRefGoogle Scholar
  41. 41.
    Rothwell PM, Goldstein LB: Carotid endarterectomy for asymptomatic stenosis: Asymptomatic Carotid Surgery Trial. Stroke 2004, 35:2425–2427.PubMedCrossRefGoogle Scholar
  42. 42.
    Halliday A, Mansfield A, Marro J, et al.; MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group: Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet 2004, 363:1491–502.PubMedCrossRefGoogle Scholar
  43. 43.
    Halliday AW, Thomas D, Mansfield A: The Asymptomatic Carotid Surgery Trial (ACST). Rationale and design. Eur J Vasc Surg 1994, 8:703–710.PubMedCrossRefGoogle Scholar
  44. 44.
    Kresowik TF, Bratzler DW, Kresowik RA, et al.: Multistate improvement in process and outcomes of carotid endarterectomy. J Vasc Surg 2004, 39:372–380.PubMedCrossRefGoogle Scholar
  45. 45.
    Rothwell PM, Warlow CP: Low risk of ischaemic stroke in patients with collapse of the internal carotid artery distal to severe carotid stenosis: cerebral protection due to low post-stenotic flow? Stroke 2000, 31:622–630.PubMedGoogle Scholar
  46. 46.
    Rothwell PM: ACST: which subgroups will benefit most from carotid endarterectomy? Lancet 2004, 364:1122–1123.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Stroke Prevention Research Unit, University Department of Clinical NeurologyRadcliffe InfirmaryOxfordUnited Kingdom

Personalised recommendations